Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuri Sato
Yuri Sato
Taisho Pharmaceutical Co.
Medicine
Type 2 Diabetes Mellitus
Renal function
Urology
Adverse effect
2
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment
2018
Clinical pharmacology in drug development
Yoshishige Samukawa
Masakazu Haneda
Yutaka Seino
Takashi Sasaki
Atsushi Fukatsu
Yusuke Kubo
Yuri Sato
Soichi Sakai
Show All
Source
Cite
Save
Citations (7)
Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus
2016
Clinical Therapeutics
Masakazu Haneda
Yutaka Seino
Nobuya Inagaki
Kohei Kaku
Takashi Sasaki
Atsushi Fukatsu
Haruka Kakiuchi
Yuri Sato
Soichi Sakai
Yoshishige Samukawa
Show All
Source
Cite
Save
Citations (41)
1